Neoaegis Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 50.00 K
as on 03-07-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -16.14%
(FY 2023)
- Profit -1199.72%
(FY 2023)
- Ebitda -856.36%
(FY 2023)
- Net Worth -494.52%
(FY 2023)
- Total Assets 8.86%
(FY 2023)
About Neoaegis Medicare
The Corporate was formerly known as Maynard Medicare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Manmohan Singh and Vikrama Nand serve as directors at the Company.
- CIN/LLPIN
U24110DL2019PTC351500
- Company No.
351500
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Neoaegis Medicare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manmohan Singh  | Additional Director | 30-Mar-2024 | Current |
| Vikrama Nand | Additional Director | 30-Mar-2024 | Current |
Financial Performance of Neoaegis Medicare.
Neoaegis Medicare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.14% decrease. The company also saw a substantial fall in profitability, with a 1199.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 494.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neoaegis Medicare?
In 2023, Neoaegis Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Martyn Nikk Pharma Private LimitedActive 5 years 5 monthsManmohan Singh and Vikrama Nand are mutual person
- Pranshul Lifesciences Private LimitedActive 4 years 6 months
Manmohan Singh and Vikrama Nand are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neoaegis Medicare?
Neoaegis Medicare has a workforce of 34 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neoaegis Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neoaegis Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
